About The Study: In this case-control study including 6,122 patients with hematologic cancers and SARS-CoV-2 infection, odds of severe COVID-19 remained high through mid-2022 despite vaccination, especially in patients requiring treatment.
Authors: Paul A. Monach, M.D., Ph.D., of the VA Boston Cooperative Studies Program in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.0288)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.0288?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=022324
About JAMA Network Open : JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open